Category: Psychopharmacology

Social Phobia in “DSM-IV-TR”

One of the anxiety disorders classified in the DSM-IV-TR is Social Phobia. This can be more deleterious than, say a snake phobia—a social phobia can cause withdrawal from so many important events in one’s life. Social phobia can include fear and avoidance of social situations because of fear of scrutiny and judgment. The person recognizes […]

By:

Generalized Anxiety Disorder

What Freud called “free floating anxiety” is now known in the DSM-IV TR as Generalized Anxiety Disorder. It’s excessive worry that can’t be controlled by the person who is experiencing it. Symptoms may include restlessness, fatigue, difficulty concentrating, irritability, tension, and sleep disturbances; when several of these reach the point of interfering with an important […]

By:

APA Guidelines on Disabilities

The American Psychological Association has announced, in the January 2012 issue of American Psychologist, “Guidelines for Assessment of and Intervention With Persons of Disabilities.” This document lists twenty-two practice-guidelines for psychologists who work with persons displaying disabilities of various kinds. The task force for this report was chaired by Kurt F. Geisinger of the University […]

By:

American Psychological Association Announces Guidelines for Psychologist Involvement in Pharmacological Issues

In the recent yearly “Reports of the Association” issue of the American Psychologist (December 2011), the American Psychological Association announced “Practice Guidelines Regarding Psychologists’ Involvement in Pharmacological Issues.” This report notes several factors that will make psychologists more involved in medication-management issues. One survey noted that the number of Americans using antidepressants increased from 6.7 […]

By:
1 2